The Centers for Medicare & Medicaid Services (“CMS”) Center for Medicare and Medicaid Innovation proposed to lower the cost of Medicare Part B outpatient prescription drugs by establishing their prices based on lower drug prices of other advanced industrial nations as compiled in an “international price index” (“IPI”) and changing the way the current drug... READ MORE
CMS Proposes Major Change to Medicare Part B Drug Payment System Introducing International Pricing Index Model
Posted on November 9, 2018 in Health Law News
Published by: Hall Render
